Nile Polymer-Free Bifurcation DES
The Nile® Polymer-free DES is a provisional stenting option for management of bifurcation lesions. It is uniquely designed with a thin strut (73µm) chromium cobalt main branch stent with dedicated delivery system.
SPECIFICATION
- Polymer-free abluminal paclitaxel layer (5µm). Semi-crystalline coating ensures 98% of the drug delivered to the lesion
- Complete reversion to regular chromium cobalt stent at 45 days
- Modular stent design provides homogenous coverage at the carina without cell overstretch
- Unique design means no angulation restrictions
- Two ultra-low profile balloons
- Two independent Rx PTCA catheters, one stent
- Compatible with 6F guide catheter
- Peel away on catheter shaft enables simple loading of device
CLINICAL DATA
- Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre BIPAX clinical trial – click here
- Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial – click here
- Learn more about the BIPAX clinical trial – click here
Resources
Product Brochure
Instructions for Use
BIPAX Final Report – 60 months follow-up